InFo 124M – Swiss Made EDOF IOL for Cataract Surgery
The company Swiss Advanced Vision (SAV-IOL SA - www.sav-iol.com ) continues to expand its portfolio of intraocular lenses (IOLs) announcing the launch of a new product range based on the first InFo series released in January 2016. InFo lenses are designed to replace the crystalline after the cataract surgery providing patients a vision free of glasses, avoiding unwanted visual adverse effects, and preserving the resolution.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170119005729/en/
The IOL InFo 124M is designed with an overall diameter of 12.4 mm to accommodate with large capsular bags. “With InFo 124M, we consolidate our current product range allowing more patients to benefit from our technology” says Max Boysset, CEO of Swiss Advanced Vision. “We are now working to enlarge our portfolio still using the Instant Focus ® technology with more affordable solutions on one hand and very high-end products on the other hand to consolidate our offer with regards to cataract surgery”.
InFo lenses are designed to provide patients suffering from cataract a high-quality solution to retrieve a continuous vision free of glasses. Due to its unique design and the use of the patented technology Instant Focus® , the InFo lens reduces dysphotopsia to nearly zero.
The Instant Focus® technology allows to extend the depth of focus (EDOF) providing a continuous near and intermediate vision free of halos, while preserving the resolution and contrast sensitivity. Due to the non-diffractive approach, the brain is not confused with multiple focal points and gets adapted much faster to its new vision.
Direct Line : +41 32 566 54 05
Route des Falaises 74
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ASTRAZENECA19.11.2017 00:02 | pressemeddelelse
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases
ASTRAZENECA18.11.2017 19:22 | pressemeddelelse
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer
CHINA-HI-TECH-FAIR18.11.2017 10:13 | pressemeddelelse
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled
NY-MADISON-REALTY17.11.2017 17:22 | pressemeddelelse
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn
NCARDIA17.11.2017 13:33 | pressemeddelelse
Ncardia Announces Completion of €10.5M Investment Round
VOCALINK17.11.2017 10:37 | pressemeddelelse
Double Win for Vocalink at the 2017 Payments Awards
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum